Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic MelanomaTeresa E. Williams, Daniel Poon, Alicia K. Louie et al.|ACS Medicinal Chemistry Letters|2015Cited by 54
Design, Structure–Activity Relationship, and in Vivo Characterization of the Development Candidate NVP-HSP990Christopher M. McBride, Cynthia M. Shafer, Barry H. Levine et al.|Journal of Medicinal Chemistry|2014Cited by 28
CHIR-265 is a potent selective inhibitor of c-Raf/B-Raf/mutB-Raf that effectively inhibits proliferation and survival of cancer cell lines with Ras/Raf pathway mutationsPayman Amiri, Renhow Paul, Mina Aikawa et al.|Cancer Research|2006Cited by 25
Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase InhibitorsSharadha Subramanian, Savithri Ramurthy, Abran Costales et al.|ACS Medicinal Chemistry Letters|2014Cited by 13